Martingale Asset Management »

Amylyx Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $405k 23k 17.96

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Commodore Capital
Jupiter Topco
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
Driehaus Capital Management
First Light Asset Management
Franklin Resources
Goldman Sachs Group
State Street Corporation
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals